A miRNA-based signature predicts development of disease recurrence in HER2 positive breast cancer after adjuvant trastuzumab-based treatment | |
Du, F.; Yuan, P.; Zhao, Z. T.; Yang, Z.; Wang, T.; Zhao, J. D.; Luo, Y.; Ma, F.; Wang, J. Y.; Fan, Y. | |
2016 | |
卷号 | 6页码:33825 |
ISSN号 | 2045-2322 |
DOI | 10.1038/srep33825 |
URL标识 | 查看原文 |
收录类别 | SCIE ; PUBMED |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6384201 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Du, F.,Yuan, P.,Zhao, Z. T.,et al. A miRNA-based signature predicts development of disease recurrence in HER2 positive breast cancer after adjuvant trastuzumab-based treatment[J],2016,6:33825. |
APA | Du, F..,Yuan, P..,Zhao, Z. T..,Yang, Z..,Wang, T..,...&Xu, B. H..(2016).A miRNA-based signature predicts development of disease recurrence in HER2 positive breast cancer after adjuvant trastuzumab-based treatment.,6,33825. |
MLA | Du, F.,et al."A miRNA-based signature predicts development of disease recurrence in HER2 positive breast cancer after adjuvant trastuzumab-based treatment".6(2016):33825. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论